“The Pink Sheet” regularly provides coverage of noteworthy biopharmaceutical business deals. Here is a round-up of the most significant deals that occurred between March 13-20. Valeant/Salix Valean
IN VITRO DIAGNOSTICS Mergers & Acquisitions DNA Electronics Ltd. NanoMR Inc. Providing it with an entry into the US market, UK-based DNA Electronics Ltd. (DNAe) paid $24mm in cash for nanoMR Inc
A recent debate in high tech circles called into question the predictive value of a large Series A financing. The discussion was sparked by venture capitalist Fred Wilson who posited in a blog that st